Mohr David C, Schueller Stephen M, Tomasino Kathryn Noth, Kaiser Susan M, Alam Nameyeh, Karr Chris, Vergara Jessica L, Gray Elizabeth L, Kwasny Mary J, Lattie Emily G
Center for Behavioral Intervention Technologies, Northwestern University, Chicago, IL, United States.
Department of Psychological Science, University of California, Irvine, Irvine, CA, United States.
J Med Internet Res. 2019 Aug 28;21(8):e13609. doi: 10.2196/13609.
IntelliCare is a modular platform that includes 12 simple apps targeting specific psychological strategies for common mental health problems.
This study aimed to examine the effect of 2 methods of maintaining engagement with the IntelliCare platform, coaching, and receipt of weekly recommendations to try different apps on depression, anxiety, and app use.
A total of 301 participants with depression or anxiety were randomized to 1 of 4 treatments lasting 8 weeks and were followed for 6 months posttreatment. The trial used a 2X2 factorial design (coached vs self-guided treatment and weekly app recommendations vs no recommendations) to compare engagement metrics.
The median time to last use of any app during treatment was 56 days (interquartile range 54-57), with 253 participants (84.0%, 253/301) continuing to use the apps over a median of 92 days posttreatment. Receipt of weekly recommendations resulted in a significantly higher number of app use sessions during treatment (overall median=216; P=.04) but only marginal effects for time to last use (P=.06) and number of app downloads (P=.08). Coaching resulted in significantly more app downloads (P<.001), but there were no significant effects for time to last download or number of app sessions (P=.36) or time to last download (P=.08). Participants showed significant reductions in the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) across all treatment arms (P s<.001). Coached treatment led to larger GAD-7 reductions than those observed for self-guided treatment (P=.03), but the effects for the PHQ-9 did not reach significance (P=.06). Significant interaction was observed between receiving recommendations and time for the PHQ-9 (P=.04), but there were no significant effects for GAD-7 (P=.58).
IntelliCare produced strong engagement with apps across all treatment arms. Coaching was associated with stronger anxiety outcomes, and receipt of recommendations enhanced depression outcomes.
ClinicalTrials.gov NCT02801877; https://clinicaltrials.gov/ct2/show/NCT02801877.
IntelliCare是一个模块化平台,包含12个针对常见心理健康问题的特定心理策略的简单应用程序。
本研究旨在探讨两种维持与IntelliCare平台互动的方法、指导以及接收尝试不同应用程序的每周推荐对抑郁、焦虑和应用程序使用情况的影响。
共有301名患有抑郁或焦虑症的参与者被随机分配到4种为期8周的治疗方案中的一种,并在治疗后随访6个月。该试验采用2×2析因设计(指导治疗与自我指导治疗以及每周应用程序推荐与无推荐)来比较参与指标。
治疗期间最后一次使用任何应用程序的中位时间为56天(四分位间距54 - 57),253名参与者(84.0%,253/301)在治疗后中位92天内持续使用这些应用程序。接收每周推荐导致治疗期间应用程序使用次数显著增加(总体中位值 = 216;P = 0.04),但对最后一次使用时间(P = 0.06)和应用程序下载次数(P = 0.08)只有边际效应。指导导致应用程序下载次数显著更多(P < 0.001),但对最后一次下载时间、应用程序使用次数(P = 0.36)或最后一次下载时间(P = 0.08)没有显著影响。所有治疗组的患者健康问卷 - 9(PHQ - 9)和广泛性焦虑障碍 - 7(GAD - 7)得分均显著降低(P值 < 0.001)。指导治疗导致GAD - 7得分的降低幅度大于自我指导治疗(P = 0.03),但对PHQ - 9的影响未达到显著水平(P = 0.06)。在接收推荐和时间方面,观察到PHQ - 9有显著交互作用(P = 0.04),但对GAD - 7没有显著影响(P = 0.58)。
IntelliCare在所有治疗组中都能使患者与应用程序保持高度互动。指导与更强的焦虑改善结果相关,接收推荐增强了抑郁改善结果。
ClinicalTrials.gov NCT02801877;https://clinicaltrials.gov/ct2/show/NCT02801877 。